Skip to main navigation Skip to search Skip to main content

ADVANTAGE visceral pain consortium: Advanced Discovery of Visceral Analgesics via Neuroimmune Targets and the Genetics of Extreme Human Phenotype

Project Details

StatusFinished
Effective start/end date1/07/21 → 30/06/25

Funding

  • MRC: £651,277.00